Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€123.30
17.08.21
-
17.08.22
-27.01%
12.01.22

Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€123.30
17.08.21
-
17.08.22
-27.01%
12.01.22

buy
Novavax Inc.

Start price
Target price
Perf. (%)
€183.96
17.12.21
€240.00
17.12.22
-37.46%
10.01.22

Could be worthwhile Investment >10% per year
Some uniques
buy
Genocea Biosciences Inc.

Start price
Target price
Perf. (%)
€1.15
27.12.21
-
27.12.22
-18.26%
10.01.22

Could be worthwhile Investment >10% per year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€134.44
30.12.21
-
30.12.22
-13.81%
09.01.22

Risky Investment
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€33.72
03.01.22
-
03.01.23
-14.00%
09.01.22

Risky Investment
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.54
03.01.22
-
03.01.23
-14.69%
09.01.22

Risky Investment
buy
Radius Health Inc.

Start price
Target price
Perf. (%)
€6.35
26.12.21
-
26.12.22
-7.81%
09.01.22

Risky Investment
buy
Carisma Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.58
21.08.21
€220.00
21.08.22
-13.54%
08.01.22

Revenue growth >5% per year expected
Undervalued
Probably not worthwhile Investment
Lower EBIT Margin than peer group
buy
Valneva SE

Start price
Target price
Perf. (%)
€19.03
04.01.22
-
04.01.23
-7.46%
07.01.22

Risky Investment
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€147.98
05.12.21
-
05.12.22
-23.17%
07.01.22

Could be worthwhile Investment >10% per year
Infinity Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.92
28.07.21
-
28.07.22
-25.00%
06.01.22

Probably not worthwhile Investment
High valuation
buy
Organovo Holdings Inc.

Start price
Target price
Perf. (%)
€10.05
05.01.21
-
05.01.22
-68.70%
06.01.22

Could be worthwhile Investment >10% per year
buy
Organovo Holdings Inc.

Start price
Target price
Perf. (%)
€10.20
01.01.21
€7.00
01.01.22
-66.98%
02.01.22

Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
High Investments for future growth
buy
Stratec SE

Start price
Target price
Perf. (%)
€122.40
30.12.20
€128.00
30.12.21
12.75%
31.12.21

Could be worthwhile Investment >10% per year
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.26
12.12.21
-
12.12.22
9.82%
25.12.21

Could be very worthwhile Investment >20% year
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€45.60
12.12.21
-
12.12.22
23.60%
25.12.21

Could be very worthwhile Investment >20% year
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€3.32
12.12.21
-
12.12.22
2.65%
25.12.21

Could be very worthwhile Investment >20% year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€151.40
12.12.21
-
12.12.22
5.67%
25.12.21

Could be very worthwhile Investment >20% year
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
12.12.21
-
12.12.22
8.73%
25.12.21

Could be very worthwhile Investment >20% year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.66
12.12.21
-
12.12.22
-1.27%
25.12.21

Could be worthwhile Investment >10% per year
buy
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€2.48
12.12.21
-
12.12.22
25.48%
25.12.21

Could be worthwhile Investment >10% per year
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.49
12.12.21
-
12.12.22
4.74%
25.12.21

Could be worthwhile Investment >10% per year
buy
Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€3.49
21.12.21
-
21.12.22
7.56%
25.12.21

Risky Investment
buy
Radius Health Inc.

Start price
Target price
Perf. (%)
€6.70
12.12.21
-
12.12.22
-5.19%
25.12.21

Could be worthwhile Investment >10% per year